Pan, N.; Cao, P.; Chen, B.; Chen, L.; Liao, X.; Ning, Y.
CX3CR1–TLR4 Axis as a Shared Neuroimmune Target in COVID-19 and Epilepsy: Integrative Transcriptomics and Gabapentin Repositioning. Biomedicines 2025, 13, 2133.
https://doi.org/10.3390/biomedicines13092133
AMA Style
Pan N, Cao P, Chen B, Chen L, Liao X, Ning Y.
CX3CR1–TLR4 Axis as a Shared Neuroimmune Target in COVID-19 and Epilepsy: Integrative Transcriptomics and Gabapentin Repositioning. Biomedicines. 2025; 13(9):2133.
https://doi.org/10.3390/biomedicines13092133
Chicago/Turabian Style
Pan, Nannan, Penghui Cao, Ben Chen, Li Chen, Xuezhen Liao, and Yuping Ning.
2025. "CX3CR1–TLR4 Axis as a Shared Neuroimmune Target in COVID-19 and Epilepsy: Integrative Transcriptomics and Gabapentin Repositioning" Biomedicines 13, no. 9: 2133.
https://doi.org/10.3390/biomedicines13092133
APA Style
Pan, N., Cao, P., Chen, B., Chen, L., Liao, X., & Ning, Y.
(2025). CX3CR1–TLR4 Axis as a Shared Neuroimmune Target in COVID-19 and Epilepsy: Integrative Transcriptomics and Gabapentin Repositioning. Biomedicines, 13(9), 2133.
https://doi.org/10.3390/biomedicines13092133